Navigation Links
Study indicates pregnancy does not harm chances of survival from cancer
Date:9/27/2007

Barcelona, Spain: New research offers reassurance to women worried about whether getting pregnant after cancer treatment might worsen their prognosis.

The study by Norwegian scientists, presented today (Thursday) at the European Cancer Conference (ECCO 14) in Barcelona, found that for almost all types of cancer, the survival of women who are diagnosed during pregnancy or who became pregnant after being treated for the disease is no different from that of other female cancer patients.

The only exception was for breast cancer diagnosed during lactation, where women were 1.9 times more likely than normal to die from their cancer, said Dr Hanne Stensheim, a research fellow at the Norwegian Cancer Registry in Oslo, Norway, who led the study. We think this is mainly based on greater delay in diagnosis, rather than any influence of the lactation process itself. It may be more difficult to diagnose breast cancer during lactation because many women get lumps due to mastitis and because normal physiological changes in the breast might mask suspicious developments.

Breast cancer is one of the most common cancers diagnosed during pregnancy, but pregnancy-related breast cancer is relatively rare. Studies have suggested that between 0.2 percent and 3.8 percent of breast cancers diagnosed in women under age 50 are detected during pregnancy or the postpartum period.

In the study, the scientists tracked the cancer of 45,511 women for an average of eight years and compared the survival rates of patients who did not get pregnant with those of patients who either were diagnosed during the gestation or lactation period, or who got pregnant after cancer diagnosis and treatment.

Many women are concerned about pregnancy after cancer, as are many doctors. There have been several hypotheses for decades proposing that complex hormonal changes and immunologic alterations associated with pregnancy might promote cancer growth, Stensheim said
'/>"/>

Contact: Emma Ross
rosswrite@mac.com
34-932-308-832
ECCO-the European CanCer Conference
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...g to a new study by researchers in National Instit...g clinical signs of dementia increases with the nu...e brain. Among their findings is the observation ...ase and cerebral infarcts (strokes) is the most co...
...h International Congress on Hair Research will be ...e largest gathering of hair experts, with clinicia...disease and treatment. Whether long or short, thi... a person emotionally. Hair loss is not simply a m...
World Blood Donor Day
...known generically as anidulafungin was shown to be...nvasive candidiasis, a potentially fatal blood inf...een hobbled. This is according to a research by Dr...n Camden, New Jersey, and colleagues who published...
Other Medicine News:Health News:Mix of Disease Process in Brain Leads to Dementia 2Health News:World Largest Hair Congress Convene in Vancouver 2Health News:World Blood Donor Day 2Health News:New Anti Fungal Drug Eraxis as Good as the Older Medicine 2
(Date:10/13/2008)....5 million dollar NIH funding advances study ...al rates, MINNEAPOLIS, Oct. 13 /- Ad...ncedcirculatory.com ) announced today that it has ...m the National Institutes of,Health (NIH) to conti...n on,those who experience cardiac arrest outside a...
(Date:10/13/2008)... Announce Interim Results in January 2009 and Fina... -, EMERYVILLE, Calif., Oct. 13 /PRNewswire-First...)) (Nasdaq: NTII ) today announced that following...ion to discuss the,Viprinex(TM) (ancrod) Phase 3 c...pany plans to consolidate and analyze data from it...
(Date:10/12/2008)...and WASHINGTON, Oct. 12 /- ...announced results from an analysis,of nearly 7,500..., which,are designed to confirm the performance of...nary Stent System in real-world practice. The,two-...t reduced clinical,restenosis in patients with dia...
(Date:10/10/2008)... Oct. 10 /- Boston Scientif...chedule of the Company,s major,events and press an...ion,s,(CRF) twentieth annual Transcatheter Cardiov...hich runs from October 12 to 17 in Washington, D.C...nge of safety and,efficacy data on its TAXUS(R) Ex...
Breaking Medicine Technology:Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 2Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 3Neurobiological Technologies Announces FDA Agreement to Consolidate Viprinex Phase 3 Trials Accelerating Time to Pivotal Data 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 1Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 2Genzyme Withdraws Bioenvisions European Filing of Evoltra 28R 29 in Elderly AML Patients 4085 3The Gender Divide Starts Over Dinner 14720 1The Gender Divide Starts Over Dinner 14720 2The Gender Divide Starts Over Dinner 14720 3Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 1Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 2Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 3Floating a big idea 3A MIT demos ancient use of rafts to transport goods 2548 4American Transplant Congress 2008 Critical New Data to be Revealed in Toronto 14718 1American Transplant Congress 2008 Critical New Data to be Revealed in Toronto 14718 2
... Alequel(TM), an,individualized oral immune regula...r moderate-to-severe Crohn,s disease. Interim,data... Phase II,studies suggest that this investigationa...proved patients, quality of life compared,to place...assah,Medical Center, Jerusalem, Israel, will toda...
...Patient Populations,Studied of Any Drug-Eluting St..., Calif., May 22, 2007,/PRNewswire-FirstCall/ -- X...data from the CUSTOM II clinical trial, which asse...stigational Custom,NX(R) drug-eluting stent (DES) ...ons in patients with coronary artery disease. , Th...
Other Medicine Technology:Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 2Enzo Biochem Individualized Oral Immune Regulation Therapy May Be,Effective Approach to Treating Crohn's Disease 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 2XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 4
ICDMeister is an electronic reference containing 15,000 of the 2006 ICD-9-CM diagnosis codes. Use whichever of the four different approaches for finding codes that you .
... (Palm OS) makes the patient appointment, the char...lity of the MedPlexus System accessible through a... access to data that was previously available only...reate super bills and more. The information stored...
MD Coder v 6.0 is a charge capture for the Palm OS and Pocket PC operating systems. We have integrated the feedback from hospitals and physicians. MD Coder v 6.0 comes in three versions: Physician Ba
A Palm Pilot and Desktop utility that you can use. Search for ICD codes in your office on your computer or in the field using your Palm Pilot.
Medicine Products: